Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Accumulated Expenses (2016)

STRATA Skin Sciences' Other Accumulated Expenses history spans 5 years, with the latest figure at $1000.0 for Q2 2016.

  • For Q2 2016, Other Accumulated Expenses changed N/A year-over-year to $1000.0; the TTM value through Jun 2016 reached $1000.0, changed N/A, while the annual FY2014 figure was $234000.0, 244.12% up from the prior year.
  • Other Accumulated Expenses for Q2 2016 was $1000.0 at STRATA Skin Sciences, down from $13000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $778000.0 in Q3 2015 and bottomed at $1000.0 in Q2 2016.
  • The 5-year median for Other Accumulated Expenses is $60596.0 (2013), against an average of $118433.2.
  • The largest annual shift saw Other Accumulated Expenses decreased 29.39% in 2013 before it skyrocketed 480.29% in 2015.
  • A 5-year view of Other Accumulated Expenses shows it stood at $41000.0 in 2012, then surged by 65.85% to $68000.0 in 2013, then surged by 244.12% to $234000.0 in 2014, then surged by 232.48% to $778000.0 in 2015, then tumbled by 99.87% to $1000.0 in 2016.
  • Per Business Quant, the three most recent readings for SSKN's Other Accumulated Expenses are $1000.0 (Q2 2016), $13000.0 (Q1 2016), and $778000.0 (Q3 2015).